TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $235,980 | +29.7% | 9,500 | -21.5% | 0.19% | +47.2% |
| Q1 2023 | $181,984 | +44.9% | 12,100 | +14.0% | 0.13% | +46.0% |
| Q4 2022 | $125,599 | +173.0% | 10,617 | -0.9% | 0.09% | +200.0% |
| Q2 2022 | $46,000 | -64.6% | 10,717 | -21.7% | 0.03% | -64.6% |
| Q1 2022 | $130,000 | -42.0% | 13,692 | +16.3% | 0.08% | -49.4% |
| Q4 2021 | $224,000 | +89.8% | 11,772 | +166.0% | 0.16% | +70.5% |
| Q3 2020 | $118,000 | – | 4,425 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |